Authors:
Burt, BM
Humm, JL
Kooby, DA
Squire, OD
Mastorides, S
Larson, SM
Fong, YM
Citation: Bm. Burt et al., Using positron emission tomography with [F-18]FDG to predict tumor behavior in experimental colorectal cancer, NEOPLASIA, 3(3), 2001, pp. 189-195
Authors:
Bennett, JJ
Tjuvajev, J
Johnson, P
Doubrovin, M
Akhurst, T
Malholtra, S
Hackman, T
Balatoni, J
Finn, R
Larson, SM
Federoff, H
Blasberg, R
Fong, YM
Citation: Jj. Bennett et al., Positron emission tomography imaging for herpes virus infection: Implications for oncolytic viral treatments of cancer, NAT MED, 7(7), 2001, pp. 861-865
Authors:
Gorlick, R
Liao, AC
Antonescu, C
Huvos, AG
Healey, JH
Sowers, R
Daras, M
Calleja, E
Wexler, LH
Panicek, D
Meyers, PA
Yeh, SD
Larson, SM
Citation: R. Gorlick et al., Lack of correlation of functional scintigraphy with (99m)technetium-methoxyisobutylisonitrile with histological necrosis following induction chemotherapy or measures of P-Glycoprotein expression in high-grade osteosarcoma, CLIN CANC R, 7(10), 2001, pp. 3065-3070
Authors:
Robbins, RJ
Tuttle, RM
Sonenberg, M
Shaha, A
Sharaf, R
Robbins, H
Fleisher, M
Larson, SM
Citation: Rj. Robbins et al., Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin, THYROID, 11(9), 2001, pp. 865-869
Authors:
Kushner, BH
Yeung, HWD
Larson, SM
Kramer, K
Cheung, NKV
Citation: Bh. Kushner et al., Extending positron emission tomography scan utility to high-risk neuroblastoma: Fluorine-18 fluorodeoxyglucose positron emission tomography as sole imaging modality in follow-up of patients, J CL ONCOL, 19(14), 2001, pp. 3397-3405
Authors:
Ramos, CD
Chisin, R
Yeung, HWD
Larson, SM
Macapinlac, HA
Citation: Cd. Ramos et al., Incidental focal thyroid uptake on FDG positron emission tomographic scansmay represent a second primary tumor, CLIN NUCL M, 26(3), 2001, pp. 193-197
Authors:
Ramos, CD
Erdi, YE
Gonen, M
Riedel, E
Yeung, HWD
Macapinlac, HA
Chisin, R
Larson, SM
Citation: Cd. Ramos et al., FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection, EUR J NUCL, 28(2), 2001, pp. 155-164
Authors:
Tanswell, P
Garin-Chesa, P
Rettig, WJ
Welt, S
Divgi, CR
Casper, ES
Finn, RD
Larson, SM
Old, LJ
Scott, AM
Citation: P. Tanswell et al., Population pharmacokinetics of antifibroblast activation protein monoclonal antibody F19 in cancer patients, BR J CL PH, 51(2), 2001, pp. 177-180
Authors:
Barendswaard, EC
Humm, JL
O'Donoghue, JA
Sgouros, G
Finn, RD
Scott, AM
Larson, SM
Welt, S
Citation: Ec. Barendswaard et al., Relative therapeutic efficacy of I-125- and I-131-labeled monoclonal antibody A33 in a human colon cancer xenograft, J NUCL MED, 42(8), 2001, pp. 1251-1256
Authors:
Lovqvist, A
Humm, JL
Sheikh, A
Finn, RD
Koziorowski, J
Ruan, S
Pentlow, KS
Jungbluth, A
Welt, S
Lee, FT
Brechbiel, MW
Larson, SM
Citation: A. Lovqvist et al., PET imaging of Y-86-labeled anti-Lewis Y monoclonal antibodies in a nude mouse model: Comparison between Y-86 and In-111 radiolabels, J NUCL MED, 42(8), 2001, pp. 1281-1287
Authors:
Yeung, HWD
Cody, HS
Turlakow, A
Riedel, ER
Fey, J
Gonen, M
Nunez, R
Yeh, SD
Larson, SM
Citation: Hwd. Yeung et al., Lymphoscintigraphy and sentinel node localization in breast cancer patients: A comparison between 1-day and 2-day protocols, J NUCL MED, 42(3), 2001, pp. 420-423
Authors:
Kramer, K
Gerald, WL
Kushner, BH
Larson, SM
Hameed, M
Cheung, NKV
Citation: K. Kramer et al., Disialoganglioside G(D2) loss following monoclonal antibody therapy is rare in neuroblastoma, MED PED ONC, 36(1), 2001, pp. 194-196
Authors:
Cheung, NKV
Kushner, BH
LaQuaglia, M
Kramer, K
Gollamudi, S
Heller, G
Gerald, W
Yeh, S
Finn, R
Larson, SM
Wuest, D
Byrnes, M
Dantis, E
Mora, J
Cheung, IY
Rosenfield, N
Abramson, S
O'Reilly, RJ
Citation: Nkv. Cheung et al., N7: A novel multi-modality therapy of high risk neuroblastoma (NB) in children diagnosed over 1 year of age, MED PED ONC, 36(1), 2001, pp. 227-230
Citation: M. Gonen et al., Statistical issues in analysis of diagnostic imaging experiments with multiple observations per patient, RADIOLOGY, 221(3), 2001, pp. 763-767
Authors:
Robbins, RJ
Tuttle, RM
Sharaf, RN
Larson, SM
Robbins, HK
Ghossein, RA
Smith, A
Drucker, WD
Citation: Rj. Robbins et al., Preparation by recombinant human thyrotropin or thyroid hormone withdrawalare comparable for the detection of residual differentiated thyroid carcinoma, J CLIN END, 86(2), 2001, pp. 619-625
Citation: Dx. Kerola et Sm. Larson, Analysis of coma dust optical properties in Comet C/1995 O1 (Hale-Bopp) II. Effects of polarization, ICARUS, 149(2), 2001, pp. 351-356
Authors:
Jacobs, A
Tjuvajev, JG
Dubrovin, M
Akhurst, T
Balatoni, J
Beattie, B
Joshi, R
Finn, R
Larson, SM
Herrlinger, U
Pechan, PA
Chiocca, EA
Breakefield, XO
Blasberg, RG
Citation: A. Jacobs et al., Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo, CANCER RES, 61(7), 2001, pp. 2983-2995
Authors:
Turlakow, A
Yeung, HWD
Pui, J
Macapinlac, H
Liebovitz, E
Rusch, V
Goy, A
Larson, SM
Citation: A. Turlakow et al., Fludeoxyglucose positron emission tomography in the diagnosis of giant cell arteritis, ARCH IN MED, 161(7), 2001, pp. 1003-1007
Authors:
Gambhir, SS
Herschman, HR
Cherry, SR
Barrio, JR
Satyamurthy, N
Toyokuni, T
Phelps, ME
Larson, SM
Balatoni, J
Finn, R
Sadelain, M
Tjuvajev, J
Blasberg, R
Citation: Ss. Gambhir et al., Imaging transgene expression with radionuclide imaging technologies, NEOPLASIA, 2(1-2), 2000, pp. 118-138
Authors:
Pittas, AG
Adler, M
Fazzari, M
Tickoo, S
Rosai, J
Larson, SM
Robbins, RJ
Citation: Ag. Pittas et al., Bone metastases from thyroid carcinoma: Clinical characteristics and prognostic variables in one hundred forty-six patients, THYROID, 10(3), 2000, pp. 261-268